Authors


Cassi Prosper, CPhT

Latest:

USP <797> Updated Guidelines

The long-awaited revised USP <797> guidelines will become official on November 1, 2023.


Nicolette Bruno, BPS, PharmD Candidate

Latest:

Probiotics for the Prevention of Pediatric Antibiotic-Associated Diarrhea

Evidence of the relationship between probiotics and antibiotics is lacking.


Lisette Hilton

Latest:

Medical Misinformation Consequences in Health Care

The COVID-19 pandemic and social media have resulted in extreme levels of misinformation.


Megan Gray, PharmD

Latest:

Relyvrio: A New FDA-Approved Treatment for Patients With ALS

Relyvrio is intended to slow the disease progression of amyotrophic lateral sclerosis.


Douglas Newton, MD, MPH

Latest:

Navigating and Treating 'New Year Depression' in Patients

There may not be a diagnosis for ‘New Year Depression,’ but about 10% to 20% of individuals in the US may get a milder form of these winter blues.


Luz Rosario, PharmD candidate

Latest:

Navigating Pediatric ADHD Medication Shortages

Stimulant medications are the first-line pharmacologic therapy for ADHD, but many of these medications are currently in short supply.


David Cates, PhD

Latest:

Ethical, Practical Considerations of Exemptions to Employer Vaccine Mandates for Anxiety

Does anxiety justify an exemption from vaccine mandates among health care workers?


Emily Diseroad, PharmD, BCPPS

Latest:

Review: Harmful Excipients for Pediatric Patients

Evidence suggests some pharmaceutical excipients in medications may have adverse effects on pediatric patients. Here’s what you should know.


Mike Gladstone

Latest:

Payers Need to Make Effort for Improvements in Biosimilars

Efforts to improve education on biosimilars are a start, but payer policies must catch up to ensure real change.


Youssef Bessada, PharmD

Latest:

Fenfluramine for the Treatment of Seizures Associated With Dravet Syndrome

On June 25, 2020, fenfluramine (Fintepla) was approved for the treatment of seizures associated with Dravet syndrome in patients 2 years and older.


Edgar Galvan

Latest:

The Future Looks Busy for Pharmacy Technicians in Immunization Programs

During COVID-19, pharmacy technicians helped keep immunization programs running.


Zoe Wainer, MBBS, PhD

Latest:

Mind-Body Resilience for Women: A Focus on Depression

Developing innovative solutions for women with depression, accounting for differences in gender and sex, are critically important


Leslie Moore, CPhT

Latest:

What Does an Oncology Pharmacy Technician Do?

From compounding to cleaning, oncology pharmacy technicians take on key responsibilities in infusion centers.


Victor Agbafe, B.A.

Latest:

How Can Improving Provider-Patient Relationships Help Reverse Chronic Disease?

The existing approach to disease management may be ill-suited to address the dynamic and diverse factors at play when it comes to chronic illness.


Wade Tung, PharmD candidate

Latest:

Review of FDA Approvals for Pediatric Obesity Management

GLP-1 receptor agonists, used to manage diabetes, are now being used for obesity in children and adolescents.


Jessica Calihan, MD

Latest:

Cannabinoid Hyperemesis Syndrome: Diagnosis and Management

A deep dive for pharmacists into this frequently debilitating disorder


Mary Scoviak

Latest:

Simplifying Widespread Itch Care with Targeted Solutions

Matthew Zirwas, MD, shares his step-by-step pearls for quelling the pruritic skin condition.


Hooman Kashi, PharmD candidate

Latest:

Abrocitinib for Atopic Dermatitis

The drug’s approval was based on the results of 3 clinical trials.


Bailey Smith, PharmD

Latest:

Navigating Pediatric ADHD Medication Shortages

Stimulant medications are the first-line pharmacologic therapy for ADHD, but many of these medications are currently in short supply.


Paul Zarutskie, MD

Latest:

Mind-Body Resilience for Women: A Focus on Depression

Developing innovative solutions for women with depression, accounting for differences in gender and sex, are critically important



Cameron Santoro

Latest:

Assessing Pharmacist Attitudes on Biosimilar Dispensing Before, After COVID-19 Pandemic

Researchers used an online English-language survey questionnaire to collect data on pharmacists from Germany and Switzerland about how their knowledge and dispensing frequency of biologics and biosimilars changed from before and after the pandemic.


Dustin Becnel, PharmD

Latest:

The Effects of “Long COVID” and How Pharmacists Can Help

Often referred to as “long COVID” patients or “long-haulers,” these patients continue to experience symptoms of illness far past the acute phase of this viral disease.


Frank Ingari

Latest:

Equity in Healthcare, Improving Access and Quality of Care

A perspective on the CMS Innovation Center roundtable on health equity.



Mary E. Schmidt, MD, MPH, FIDSA

Latest:

Detecting Crossover Symptoms of COVID-19, Influenza

As respiratory viruses and COVID-19 variants lurk seemingly everywhere, here’s how best to detect and differentiate.


Sherry G. Cohen, FNP-C, APRN-PMH

Latest:

Sun Protection and Children: A Refresher

Protection from the harsh rays of the sun is crucial for everyone—including children. Now that summer has arrived, a refresher course can go a long way in preventing skin damage and disorders due to the sun.


Colin Schleicher, PharmD candidate

Latest:

Intranasal CGRP Antagonist Is Approved for the Treatment of Acute Migraines

Zavegepant joins other CGRP antagonists as an option for individuals experiencing migraine.


Dhiren Patel, PharmD, CDCES, BC-ADM, BCACP

Latest:

Bempedoic Acid for Hypercholesterolemia

An expert panel discusses where bempedoic acid currently fits into the treatment of hypercholesterolemia.


Todd Mizeski, Esq

Latest:

US Supreme Court Hears Argument on State’s Ability to Regulate PBMs

Todd Mizeski, Esq, a Partner in Frier Levitt’s Life Sciences, Litigation Department, discusses the case of Rutledge v. Pharmaceutical Care Management Association.

© 2024 MJH Life Sciences

All rights reserved.